Germany – Postdoctoral Fellowship in Immunotherapy at Leibniz Institute Immunotherapy

About the Institute

The Leibniz Institute for Immunotherapy (LIT) is a renowned research institution in Germany dedicated to pioneering advances in immunological science and translational medicine. It brings together leading scientists from around the world to address pressing challenges in immunotherapy and cellular engineering, supported by state‑of‑the‑art infrastructure and a collaborative, interdisciplinary environment.

The postdoctoral position focuses on mitochondrial transfer and synthetic organelle therapy within T‑cell immunology. The core objective is to investigate how mitochondrial exchange influences T‑cell differentiation and memory formation, thereby improving the effectiveness of T‑cell‑based immunotherapies. Advancing organelle engineering could lead to more durable therapeutic interventions for cancer, infectious diseases, and other indications.

The project employs a variety of sophisticated methods and techniques, including genetically engineered mouse models, organelle‑tracking reporter systems, confocal & fluorescence microscopy, high‑dimensional flow cytometry, metabolic profiling (Seahorse, SCENITH), proliferation & cytotoxicity assays, cytokine multiplex analysis, and single‑cell RNA‑seq & ATAC‑seq. The successful candidate will work within an international research team, contributing to high‑impact publications and translational research that bridges basic science and clinical application.

• Genetically engineered mouse models
• Organelle‑tracking reporter systems
• Confocal & fluorescence microscopy
• High‑dimensional flow cytometry
• Metabolic profiling (Seahorse, SCENITH)
• Proliferation & cytotoxicity assays
• Cytokine multiplex analysis
• Single‑cell RNA‑seq & ATAC‑seq

• A PhD in Immunology, Cell Biology, Molecular Biology, or a closely related field
• Demonstrated experience with mouse models and in‑vivo experimental systems
• Expertise in T‑cell biology and cellular metabolism
• Strong record of scientific publications in peer‑reviewed journals
• Fluency in English, both written and spoken

Applications should be submitted via the institute’s online portal, referencing the code LG‑2026‑1. The Final date to receive applications is 1 March 2026. Please refer to the official advertisement for application details.

This postdoctoral fellowship at the Leibniz Institute for Immunotherapy offers a unique opportunity to contribute to groundbreaking research in T‑cell biology and immunotherapy. If you are driven by scientific curiosity and aspire to shape the future of cellular therapies, you are strongly encouraged to apply.